Compare
Johnson & Johnson vs Merck & (JNJ vs MRK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Merck & (MRK) +73.9%; so far this year the figures are +33.5% and +39.4%.
Johnson & Johnson is the larger company by market value, about 1.8 times the size of Merck &.
On trailing earnings, JNJ trades at 41.9 times and MRK at 149.7 times.
Revenue grew +7.8% at JNJ and +4.9% at MRK over the last year.
JNJ yields 1.91%. MRK yields 2.32%.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | MRK | |
|---|---|---|
| Price | $276.22 | $146.73 |
| 1-day | +1.43% | -0.14% |
| YTD | +33.47% | +39.40% |
| 1 year | +48.51% | +73.87% |
| 3 years | +85.77% | +42.66% |
| Market cap | $665.0B | $361.7B |
| P/E | 41.9 | 149.7 |
| P/S | 6.69 | 5.37 |
| P/B | 8.16 | 8.06 |
| Revenue growth | +7.80% | +4.90% |
| EPS growth | -36.40% | -87.10% |
| Gross margin % | 67.6 | 71.8 |
| Net margin % | 16.2 | 3.6 |
| ROE % | 19.7 | 5.5 |
| Debt / equity | 0.55 | 1.20 |
| FCF yield % | 3.1 | 4.1 |
| Dividend yield % | 1.91 | 2.32 |
| Beta | -0.09 | 0.18 |
| RSI (14) | 59.4 | 51.3 |
| Technical rating |